OR WAIT null SECS
May 30, 2019
A new facility to be built in the Philadelphia Navy Yard will support commercial production for autologous tumor-infiltrating lymphocyte cell therapy products from Iovance Biotherapeutics.
May 21, 2019
The expansion will increase the company’s single-use capacity to meet growing demand.
May 20, 2019
Catalent expands gene therapy capabilities with $1.2-billion acquisition of Paragon Bioservices.
May 16, 2019
The partnership will focus on the commercialization of inducible promoters to improve biomanufacturing.
May 14, 2019
The new 40,000-ft2 facility will support Bayer's growing biologics portfolio in oncology, cardiology, and additional therapeutic areas.
May 10, 2019
Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing for its specialist oncolytic virus and viral vector manufacturing services as a result of a growth in demand.
May 03, 2019
A data exchange program between GE Healthcare and Amgen aims to improve biologics manufacturing through analysis of how raw materials affect the process.
May 02, 2019
While the multiple attributes method gains ground and traditional lab methods improve, broad efforts are underway to determine biopharmaceuticals’ most significant critical quality attributes and enable real-time release.
Large biopharmas, emerging biotechs, and CMOs are looking for novel ways to improve the productivity of biologics in a rapidly evolving biotherapeutics market.
Single-use technology is gaining ground in downstream bioprocessing, but challenges stall further adoption.